Sami Mnaymneh's Net Worth
$741 Million
Who is Sami Mnaymneh?
Sami Mnaymneh has an estimated net worth of $741 Million. This is based on reported shares across multiple companies, which include Surgery Partners, Inc., eHealth, Inc., ONCOGENEX PHARMACEUTICALS, INC., Clarus Therapeutics Holdings, Inc., EXAGEN INC., ADVANCED ENVIRONMENTAL RECYCLING TECHNOLOGIES INC, TRANZYME INC, COMVERGE, INC., ALLION HEALTHCARE INC, MATRIXX INITIATIVES INC, ALL AMERICAN GROUP INC, and WhiteHorse Finance, Inc..
SEC CIK
Sami Mnaymneh's CIK is 0001050046
Past Insider Trading and Trends
2010 was Sami Mnaymneh's most active year for acquiring shares with 8 total transactions. Sami Mnaymneh's most active month to acquire stocks was the month of August. 2010 was Sami Mnaymneh's most active year for disposing of shares, totalling 8 transactions. Sami Mnaymneh's most active month to dispose stocks was the month of July. 2011 saw Sami Mnaymneh paying a total of $201,898,406.25 for 25,725,490.149 shares, this is the most they've acquired in one year. In 2017 Sami Mnaymneh cashed out on 41,766,065.149 shares for a total of $558,169,544.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COMVERGE, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 82.53M |
$1.75 | $144,421,187.75 |
0
|
May 15
| |||
Form 4
|
∞
| 14.41M |
$1.75 | $25,213,630.75 | 14.41M |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
eHealth, Inc. (EHTH) Snapshot price: $7.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surgery Partners, Inc. (SGRY) Snapshot price: $32.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.46M |
$19.00 | -$502,657,369.00 |
0
|
Aug 31
| |||
Form 4
| -4.77% | -1.32M |
$19.00 | -$25,164,816.00 | 26.46M |
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXAGEN INC. (XGN) Snapshot price: $2.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.7M |
$14.00 | $5,950,000.00 | 1.7M |
Sep 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONCOGENEX PHARMACEUTICALS, INC. (ACHV) Snapshot price: $4.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.49% | -100.00K |
$20.79 | -$2,078,610.00 | 545.51K |
Jun 3
| |||
Form 4
| -12.05% | -88.40K |
$21.41 | -$1,892,290.40 | 645.51K |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||